On the role of pharmacometrics in mathematical models for cancer treatments
From MaRDI portal
Publication:2026619
DOI10.3934/dcdsb.2020213zbMath1466.92077OpenAlexW3040243561MaRDI QIDQ2026619
Heinz Schättler, Urszula Łedzewicz-Kowalewska
Publication date: 20 May 2021
Published in: Discrete and Continuous Dynamical Systems. Series B (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.3934/dcdsb.2020213
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15)
Related Items (6)
The Structure of Optimal Protocols for a Mathematical Model of Chemotherapy with Antiangiogenic Effects ⋮ On the optimal control problem for a model of the synergy of chemo‐ and immunotherapy ⋮ Bang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancer ⋮ Combination of antiangiogenic treatment with chemotherapy as a multi‐input optimal control problem ⋮ Optimizing antimicrobial treatment schedules: some fundamental analytical results ⋮ On the role of the objective in the optimization of compartmental models for biomedical therapies
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Geometric optimal control. Theory, methods and examples
- Sufficient conditions for strong local optimality in optimal control problems with \(L_{2}\)-type objectives and control constraints
- The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models
- Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics. Homogeneous and heterogeneous approaches
- Role of optimal control theory in cancer chemotherapy
- On optimal delivery of combination therapy for tumors
- Optimal control applied to a generalized Michaelis-Menten model of CML therapy
- Controlling a model for bone marrow dynamics in cancer chemotherapy
- Optimization of combination therapy for chronic myeloid leukemia with dosing constraints
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Singular trajectories and their role in control theory
- Optimal bang-bang controls for a two-compartment model in cancer chemotherapy
- Optimal and suboptimal protocols for a mathematical model for tumor anti-angiogenesis in combination with chemotherapy
- Optimal control for a mathematical model for anti-angiogenic treatment with Michaelis-Menten pharmacodynamics
- Optimal control problems for the Gompertz model under the Norton-Simon hypothesis in chemotherapy
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
- Introduction to Mathematical Biology
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- Optimal control for a mathematical model for chemotherapy with pharmacometrics
- Sufficient conditions for optimality for a mathematical model of drug treatment with pharmacodynamics
- Computational Pharmacokinetics
This page was built for publication: On the role of pharmacometrics in mathematical models for cancer treatments
